← Leaderboards
Thibaut Davy-Mendez
Univ Of North Carolina Chapel Hill
$450,021
Attributed
$450,021
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $150K · FY2023–25$200K$150K$100K$50K$0
'23
'24
'25
Funding mix
By agency
NIH$450,021 · 1
By mechanism
K01$450,021 · 1
Top collaborators
No co-investigators on record.
Most similar at Univ Of North Carolina Chapel Hill
Same institution · by research overlap
- Sandra McCoy$8,770,788
- David A Wohl$27,961,733
- David Couper$42,599,822
- Deidra Candice Crews$7,461,293
- Jianwen Cai$34,203,410
Others in their field
Other Rising Stars on “Acquired Immunodeficiency Syndrome”
- Jessica Holden · Technical Resources International, Inc.$37,843,443
- Supriya Menezes · The Emmes Company, Llc$25,277,032
- Bambra Stokes · Ppd Development Lp$17,155,112
- Amber Mallory · Texas Biomedical Research Institute$8,000,000
- Shaunna Shen · Duke University$7,747,008
- Dhiraj Kumar Singh · Texas Biomedical Research Institute$3,900,756
Research focus
Acquired Immunodeficiency SyndromeAdherenceAntiretroviral TherapyAtherosclerosisAtherosclerosis RiskAwardBehavioralBehavior TherapyCardiologyCardiovascular Disorder PreventionCardiovascular Disorder RiskCareerCare ProvidersCaringCholesterolChronicChronic DiseaseClinicClinical EpidemiologyCohortCohort StudiesCo-InfectionComorbidityAcceptability And Feasibility
Grant awards (3)
Addressing Barriers to the Comprehensive Use of Statins in HIV: The ABACUS-HIV Study$150,007
K01 · FY2025 · HL · contact PI
Addressing Barriers to the Comprehensive Use of Statins in HIV: The ABACUS-HIV Study$150,007
K01 · FY2024 · HL · contact PI
Addressing Barriers to the Comprehensive Use of Statins in HIV: The ABACUS-HIV Study$150,007
K01 · FY2023 · HL · contact PI